ICIwona Cygankiewicz

Iwona Cygankiewicz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Iwona Cygankiewicz has a total of 147 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence of Lyme Carditis in Patients with Atrioventricular Blocks

    by Krzysztof A. Kaczmarek, Katarzyna Szwabe, Irmina Urbanek, Pawel Ptaszynski, Aleksander Strzelecki, Jerzy K. Wranicz, Iwona Cygankiewicz

    Infections with Borrelia may cause cardiac conduction system abnormalities, including atrioventricular blocks (AVBs). Therefore, we aimed to identify patients in whom Lyme carditis (LC) could be considered as the initial diagnosis among consecutive subjects who were referred for implantation of a permanent pacemaker due to symptomatic AVBs. To date, such a systematic evaluation has not been reported yet. Validation of the Suspicious Index for Lyme Carditis (SILC) in our study population was considered as an additional goal. We investigated consecutive patients with AVB admitted to our department for a pacemaker implantation. Serological diagnostic tests against Borrelia burgdorferi sensu lato (Bbsl) were performed in those with no obvious cardiac causes of AVB. The final study population consisted of 130 patients (80 M, mean age 67.4 ± 17.6). Lyme carditis was assumed as the initial diagnosis in 16 patients (12%) based on ABV and IgM Bbsl seropositivity. The patients with LC were younger and more frequently manifested constitutional symptoms of infection and fluctuating AVB. The highest prognostic value for identification of LC patients was obtained for the modified SILC, which included the following parameters: (1) age lower than 75 years; (2) risky outdoor activity and living in the countryside; (3) tick bite; (4) constitutional symptoms of Lyme disease; (5) erythema migrans; (6) male sex and (7) fluctuating atrioventricular block. We concluded that diagnostics for LC should be routinely considered in patients with advanced AVB. Modified SILC may identify the patients at risk of LC.


  • Top Cited Papers

    P Wave Parameters and Indices: A Critical Appraisal of Clinical Utility, Challenges, and Future Research—A Consensus Document Endorsed by the International Society of Electrocardiology and the International Society for Holter and Noninvasive Electrocardiology

    by Lin Yee Chen, Antonio Luiz Pinho Ribeiro, Pyotr G. Platonov, Iwona Cygankiewicz, Elsayed Z. Soliman, Bulent Gorenek, Takanori Ikeda, Vassilios P. Vassilikos, Jonathan S. Steinberg, Niraj Varma, et al.

    Atrial cardiomyopathy, characterized by abnormalities in atrial structure and function, is associated with increased risk of adverse cardiovascular and neurocognitive outcomes, independent of atrial fibrillation. There exists a critical unmet need for a clinical tool that is cost-effective, easy to use, and that can diagnose atrial cardiomyopathy. P wave parameters (PWPs) reflect underlying atrial structure, size, and electrical activation; alterations in these factors manifest as abnormalities in PWPs that can be readily ascertained from a standard 12-lead ECG and potentially be used to aid clinical decision-making. PWPs include P wave duration, interatrial block, P wave terminal force in V 1 , P wave axis, P wave voltage, P wave area, and P wave dispersion. PWPs can be combined to yield an index (P wave index), such as the morphology-voltage-P-wave duration ECG risk score. Abnormal PWPs have been shown in population-based cohort studies to be independently associated with higher risks of atrial fibrillation, ischemic stroke, sudden cardiac death, and dementia. Additionally, PWPs, either individually or in combination (as a P wave index), have been reported to enhance prediction of atrial fibrillation or ischemic stroke. To facilitate translation of PWPs to routine clinical practice, additional work is needed to standardize measurement of PWPs (eg, via semiautomated or automated measurement), confirm their reliability and predictive value, leverage novel approaches (eg, wavelet analysis of P waves and machine learning algorithms), and finally, define the risk-benefit ratio of specific interventions in high-risk individuals. Our ultimate goal is to repurpose the ubiquitous 12-lead ECG to advance the study, diagnosis, and treatment of atrial cardiomyopathy, thus overcoming critical challenges in prevention of cardiovascular disease and dementia.


  • Open Access

    Impedance fluctuation and steam pop occurrence during radiofrequency current ablation: An experimental in vitro model

    by Rafał Olszewski, Paweł Ptaszyński, Iwona Cygankiewicz, Krzysztof Kaczmarek

    The radiofrequency impedance measurement is one of the basic parameters monitored during ablation procedures. An abrupt rise in impedance is often observed corresponding to a steam pop. The exact correlation between the occurrence of steam pop and subsequent rise in impedance has not been experimentally described so far. To evaluate the relationship between steam pop occurrence and impedance fluctuations observed during radiofrequency ablation (RFA). Porcine heart tissue specimens were appropriately prepared and placed in an experimental setup connected to electrophysiological equipment with 3D anatomical mapping facilities. The RFA lesions were performed in standardized conditions with the use of contact force measurement-enabled open irrigation ablation catheter (ThermoCool SmartTouch™, 3.5 mm tip, F-J curvature; Biosense Webster, Irvine, USA) in the power-control mode. The RFA delivery was stopped when the steam pop occurred. Time taken for the steam pop to occur and to the subsequent abrupt impedance rise was recorded, along with the impedance fluctuations during an application. In total, 25 experimental radiofrequency (RF) current deliveries ended up with steam pops, which occurred after 30-60 s. The time recorded from the beginning of the application up to the steam pop was shorter if increased power was applied (35 W compared to 30 W: 41.5 ±9.9 s compared to 49.9 ±8.2 s; p = 0.046). During all RF applications, impedance significantly but gradually decreased from 122.9 ±7.9 Ω to 87.5 ±3.6 Ω (p < 0.001) with a mean drop rate of 0.8 ±0.2 Ω/s. During all experiments, the abrupt and significant impedance increase (8.2 ±2.0 Ω, p < 0.001) was observed always after steam pop occurrence (207.4 ±155.9 ms). During RF current delivery which ended up with steam pop, an abrupt impedance increase was always registered after the occurrence of this phenomenon. Therefore, the impedance rise observed during steam popping cannot be used for its prediction. The time to steam pop was shorter for applications with increased power but not with greater contact force.


  • Open Access

    Percutaneous Occlusion of the Left Atrial Appendage with Thrombus Irresponsive to Antithrombotic Therapy

    by Krzysztof Kaczmarek, Iwona Cygankiewicz, Witold Streb, Rafal Plaksej, Piotr Jakubowski, Zbigniew Kalarus, Pawel Ptaszynski, Jerzy Krzysztof Wranicz, Anna Babicz-Sadowska, Agata Markiewicz, et al.

    We analyzed clinical experience with percutaneous closure of instances of left atrial appendage with thrombus (LAAT) irresponsive to antithrombotic therapy in patients treated in three high-volume cardiology centers. Clinical and procedural data regarding consecutive patients who underwent percutaneous left atrial appendage closure (PLAAC) due to LAAT were retrospectively analyzed. The study population consisted of 17 patients (11 men; 68 ± 14 years; CHA2DS2VASC 4.7 ± 1.9; HASBLED 3 (0–5)) with LAAT confirmed by transesophageal echocardiography, and included 5 patients with mechanical heart valves. Most of the patients (94.1%) received anticoagulation therapy before PLAAC. All LAATs were located in distal portions of the appendage and occupied less than 30% of its volume. Occluding-device implantation was successful in 17 patients; in one, a residual leak was disclosed. Appropriate positioning of occluders required more than 1 attempt in 6 individuals (35.3%); in 3 others (17.6%), the subjects’ devices had contact with thrombi. No procedural complications were noted. Midterm follow-up (median: 10 months) revealed no procedure-related complications or clinically diagnosed thromboembolism. Transesophageal echocardiography (TEE) performed after six months revealed device-related thrombus in one patient. We concluded that LAAT irresponsive to antithrombotic therapy might be effectively treated with PLAAC, even in patients with mechanical-valve prostheses.


  • 2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society

    by Niraj Varma, Iwona Cygankiewicz, Mintu P. Turakhia, Hein Heidbuchel, Yu-Feng Hu, Lin Yee Chen, Jean-Philippe Couderc, Edmond M. Cronin, Jerry D. Estep, Lars Grieten, et al.

    This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society describes the current status of mobile health technologies in arrhythmia management. The range of digital medical tools and heart rhythm disorders that they may be applied to and clinical decisions that may be enabled are discussed. The facilitation of comorbidity and lifestyle management (increasingly recognized to play a role in heart rhythm disorders) and patient self-management are novel aspects of mobile health. The promises of predictive analytics but also operational challenges in embedding mobile health into routine clinical care are explored.


  • Open Access

    2021 ISHNE/ HRS/ EHRA/ APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals

    by Niraj Varma, Iwona Cygankiewicz, Mintu Turakhia, Hein Heidbuchel, Yufeng Hu, Lin Yee Chen, Jean‐Philippe Couderc, Edmond M. Cronin, Jerry D. Estep, Lars Grieten, et al.

    This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology/ Heart Rhythm Society/ European Heart Rhythm Association/ Asia Pacific Heart Rhythm Society describes the current status of mobile health ("mHealth") technologies in arrhythmia management. The range of digital medical tools and heart rhythm disorders that they may be applied to and clinical decisions that may be enabled are discussed. The facilitation of comorbidity and lifestyle management (increasingly recognized to play a role in heart rhythm disorders) and patient self‐management are novel aspects of mHealth. The promises of predictive analytics but also operational challenges in embedding mHealth into routine clinical care are explored.


  • Open Access

    2021 ISHNE / HRS / EHRA / APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals

    by Niraj Varma, Iwona Cygankiewicz, Mintu Turakhia, Hein Heidbuchel, Yufeng Hu, Lin Yee Chen, Jean-Philippe Couderc, Edmond M Cronin, Jerry D Estep, Lars Grieten, et al.

    This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology / Heart Rhythm Society / European Heart Rhythm Association / Asia Pacific Heart Rhythm Society describes the current status of mobile health (“mHealth”) technologies in arrhythmia management. The range of digital medical tools and heart rhythm disorders that they may be applied to and clinical decisions that may be enabled are discussed. The facilitation of comorbidity and lifestyle management (increasingly recognized to play a role in heart rhythm disorders) and patient self-management are novel aspects of mHealth. The promises of predictive analytics but also operational challenges in embedding mHealth into routine clinical care are explored.


  • Open Access

    2021 ISHNE/HRS/EHRA/APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals

    by Niraj Varma, Iwona Cygankiewicz, Mintu Turakhia, Hein Heidbuchel, Yufeng Hu, Lin Yee Chen, Jean‐Philippe Couderc, Edmond M. Cronin, Jerry D. Estep, Lars Grieten, et al.

    This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society describes the current status of mobile health (“mHealth”) technologies in arrhythmia management. The range of digital medical tools and heart rhythm disorders that they may be applied to and clinical decisions that may be enabled are discussed. The facilitation of comorbidity and lifestyle management (increasingly recognized to play a role in heart rhythm disorders) and patient self‐management are novel aspects of mHealth. The promises of predictive analytics but also operational challenges in embedding mHealth into routine clinical care are explored.


  • Open Access

    Sudden Cardiac Death Prediction in Chronic Heart Failure Patients by Periodic Repolarization Dynamics

    by Saúl Palacios, Iwona Cygankiewicz, Antoni Bayés-De-Luna, Juan Pablo Martínez, Esther Pueyo